Sugi Predict

Sugi Predict / Compounds / SCHEMBL2880111

SCHEMBL2880111

SCHEMBL2880111

Clc1nc2ccncc2c2c(Cl)nccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 5/20 0.36
▸ IMPDH2 P12268 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ PMP22 Q01453 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HIPK2 Q9H2X6 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ CSNK2A2 P19784 2/20 0.33
▸ CSNK2B P67870 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ MAPK10 P53779 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2458480 0.86 LMNA (0.39) JAK2IMPDH2LMNACYP3A4MAPT
SCHEMBL2875572 0.79 LRRK2 (0.43) JAK2HPGDSMN1; SMN2KDM4C
SCHEMBL2879558 0.74 JAK2 (0.53) JAK2CSNK2A2CSNK2BCDK2
SCHEMBL2881698 0.73 HTT (0.45) LMNAKDM4EALDH1A1HIPK2DHODH
SCHEMBL2877424 0.73 DHODH (0.39) MAPTMAPK1KDM4EALDH1A1HIPK2
SCHEMBL2461725 0.72 IMPDH2 (0.33) JAK2IMPDH2LMNACYP3A4MAPT
SCHEMBL25722017 0.72 IMPDH2 (0.36) JAK2IMPDH2LMNAMAPTKDM4E
SCHEMBL2688103 0.72 ACHE (0.41) IMPDH2HIPK2CSNK2A2CSNK2BKDM4C
SCHEMBL30593380 0.72 IMPDH2 (0.36) JAK2IMPDH2LMNAMAPTKDM4E
SCHEMBL2877188 0.72 JAK2 (0.68) JAK2CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349865-B2 Inhibitors of janus kinases MERCK SHARP & DOHME CORP. (US) 2013-01-08 — — US disclosed
US-8349865-B2 Inhibitors of janus kinases MERCK SHARP & DOHME CORP. (US) 2013-01-08 — — US disclosed
US-8349865-B2 Inhibitors of janus kinases MERCK SHARP & DOHME CORP. (US) 2013-01-08 — — US disclosed
EP-2200612-B1 INHIBITORS OF JANUS KINASES SCHERING CORP (US) 2012-08-08 — — EP disclosed
EP-2200612-B1 INHIBITORS OF JANUS KINASES SCHERING CORP (US) 2012-08-08 — — EP disclosed
US-20100197634-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2010-08-05 — — US disclosed
US-20100197634-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2010-08-05 — — US disclosed
US-20100197634-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2010-08-05 — — US disclosed
EP-2200612-A1 INHIBITORS OF JANUS KINASES Merck Sharp & Dohme Corp. (US) 2010-06-30 — — EP disclosed
WO-2009035575-A1 INHIBITORS OF JANUS KINASES MERCK & CO., INC. (US) 2009-03-19 — — WO disclosed
WO-2009035575-A1 INHIBITORS OF JANUS KINASES MERCK & CO., INC. (US) 2009-03-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197634-A1 INHIBITORS OF JANUS KINASES JAK2, JAK3, JAK1 JAK2 1/4885IMPDH2 2494/4885LMNA 4183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.